All News and Events


Dana Solutions invited to speak at Southern California Regional Chapter of SOT

Our presentation is part of the session on Computational Toxicology – The Cutting-edge of In Silico Prediction, and is titled "Applications of Artificial Intelligence in Preclinical Drug Efficacy and Safety Testing."


Dana Solutions to present at Neuroscience 2019

Come see our poster #707 titled "In-Vitro Structural Neurotoxicity Testing Using Deep Convolutional Neural Networks" on Wednesday October 23 at 8am-12pm in McCormick Place Hall A.


Dana Solutions part of HESI U01 award from the FDA to study cardiac failure modes

Dana Solutions announced today that it will receive a subaward from the Health and Environmental Sciences Institute (HESI) as part of a multi-year U01 grant from the FDA.


Dana Solutions to present at 2019 ISSCR Annual Meeting

Come see our poster T-3222 titled "Artificial Intelligence Captures Structural Toxicity in Human In Vitro Cell Models on Thursday June 27 at 7pm in Poster Session II Even.


Dana Solutions to present and exhibit at 2019 SOT Annual Meeting and ToxExpo

Come visit us at booth #2312, and see our poster P365 titled "A Novel Tool For Structural Toxicity Testing With In Vitro Models" on Thursday March 14 from 8:30am to 11:30am.


FDA signs collaborative agreement with Dana Solutions to apply deep-learning algorithms for drug safety testing

Dana Solutions announced today that it has entered into a Research Collaboration Agreement with the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research.


Dana Solutions presents at the Gladstone Institutes MicroBites Seminar

We were invited to present to researchers at the Gladstone Institutes, and talk about how PhenoLearn can be used for image-based phenotypic modeling, drug screening, quality control, and more.